Search

Your search keyword '"SALL4"' showing total 975 results

Search Constraints

Start Over You searched for: Descriptor "SALL4" Remove constraint Descriptor: "SALL4" Publication Year Range Last 50 years Remove constraint Publication Year Range: Last 50 years
975 results on '"SALL4"'

Search Results

1. CircSFMBT2 Plays an Oncogenic Role in Lung Adenocarcinoma Depending on the miR-1305/SALL4 Axis.

2. Silencing AREG Enhances Sensitivity to Irradiation by Suppressing the PI3K/AKT Signaling Pathway in Colorectal Cancer Cells.

3. Fetal gut cell-like differentiation in esophageal adenocarcinoma defines a rare tumor subtype with therapeutically relevant claudin-6 positivity and SWI/SNF gene alteration

4. Diagnostic Value of SALL4 and OCT3/4 in Pediatric Testicular Tumors.

5. Assessment of Molecular Markers in Pediatric Ovarian Tumors: Romanian Single-Center Experience.

6. Sall genes regulate hindlimb initiation in mouse embryos.

7. SALL4 deletion and kidney and cardiac defects associated with VACTERL association.

8. Human Genetics of Ventricular Septal Defect

9. SALL4 in gastrointestinal tract cancers: upstream and downstream regulatory mechanisms

10. Expression of Fascin and SALL4 in odontogenic cysts and tumors: an immunohistochemical appraisal. [version 5; peer review: 2 approved, 1 approved with reservations, 2 not approved]

11. Expression of Fascin and SALL4 in odontogenic cysts and tumors: an immunohistochemical appraisal. [version 4; peer review: 1 approved, 2 approved with reservations, 2 not approved]

12. SALL4 in gastrointestinal tract cancers: upstream and downstream regulatory mechanisms.

13. Sall4 regulates posterior trunk mesoderm development by promoting mesodermal gene expression and repressing neural genes in the mesoderm.

14. Integrative Role of the SALL4 Gene: From Thalidomide Embryopathy to Genetic Defects of the Upper Limb, Internal Organs, Cerebral Midline, and Pituitary.

15. Expression of Fascin and SALL4 in odontogenic cysts and tumors: an immunohistochemical appraisal. [version 5; peer review: 1 approved, 2 approved with reservations, 2 not approved]

16. Expression of Fascin and SALL4 in odontogenic cysts and tumors: an immunohistochemical appraisal. [version 4; peer review: 1 approved, 2 approved with reservations, 1 not approved]

17. Expression of CD44 and SALL4 in Leukoplakia and Oral Squamous Cell Carcinoma

18. Colostomy‐site carcinoma with primitive phenotype in a rectal cancer patient after achieving pathological complete response with neoadjuvant chemoradiotherapy.

19. Sall1 and Sall4 cooperatively interact with Myocd and SRF to promote cardiomyocyte proliferation by regulating CDK and cyclin genes.

20. Diagnostic Value of SALL4 and OCT3/4 in Pediatric Testicular Tumors

21. Assessment of Molecular Markers in Pediatric Ovarian Tumors: Romanian Single-Center Experience

23. Expression of Fascin and SALL4 in odontogenic cysts and tumors: an immunohistochemical appraisal. [version 3; peer review: 2 approved with reservations, 1 not approved]

24. SALL4 promotes angiogenesis in gastric cancer by regulating VEGF expression and targeting SALL4/VEGF pathway inhibits cancer progression

25. SALL4‐related gene signature defines a specific stromal subset of pancreatic ductal adenocarcinoma with poor prognostic features

26. SALL4 correlates with proliferation, metastasis, and poor prognosis in prostate cancer by affecting MAPK pathway

27. Sall4 restricts glycolytic metabolism in limb buds through transcriptional regulation of glycolytic enzyme genes.

28. Ovarian Mucinous Carcinoma with a Yolk sac Tumor-Like Component: A Report of Three Cases with a Literature Review for Prognostic Analysis.

29. SALL4 as an indicator for the diagnosis of hepatoid carcinoma of the ovary: A case report and literature review.

30. Expression of Fascin and SALL4 in odontogenic cysts and tumors: an immunohistochemical appraisal. [version 2; peer review: 2 approved with reservations, 1 not approved]

31. SALL4 as an indicator for the diagnosis of hepatoid carcinoma of the ovary: A case report and literature review

32. SALL4 promotes angiogenesis in gastric cancer by regulating VEGF expression and targeting SALL4/VEGF pathway inhibits cancer progression.

33. SALL4‐related gene signature defines a specific stromal subset of pancreatic ductal adenocarcinoma with poor prognostic features.

34. SALL4 correlates with proliferation, metastasis, and poor prognosis in prostate cancer by affecting MAPK pathway.

35. Ovary

36. Co-overexpression of self-renewal markers SALL4 and HIWI is correlated with depth of tumor invasion and metastasis in colorectal cancer

37. Dual-Regulated Mechanism of EZH2 and KDM6A on SALL4 Modulates Tumor Progression via Wnt/β-Catenin Pathway in Gastric Cancer.

38. Salt‐like transcription factor 4 promotes laryngeal cancer progression through transcriptional activation of ubiquitin‐specific protease 21 to stabilize Yin Yang 1.

39. Expression and clinicopathological characteristics of PDX1, PTF1A, and SALL4 in large and small ducts of ectopic pancreas located in gastro-duodenum and jejunum

40. Case Report: A Rare Case of Hepatoid Adenocarcinoma in Stomach and Duodenum Simultaneously

41. Identification of SALL4 Expressing Islet-1+ Cardiovascular Progenitor Cell Clones.

42. Production and characterization of a new specific monoclonal antibody against A‐isoform of SALL4: A novel emerging testicular cancer marker.

43. Role of SALL4 in HER2+ Breast Cancer Progression: Regulating PI3K/AKT Pathway.

44. Sall4 Guides p53-Mediated Enhancer Interference upon DNA Damage in Mouse Embryonic Stem Cells.

45. Expression of Fascin and SALL4 in odontogenic cysts and tumors: an immunohistochemical appraisal. [version 1; peer review: 2 approved with reservations, 1 not approved]

46. Co-expression of cancer stem cell markers, SALL4/ALDH1A1, is associated with tumor aggressiveness and poor survival in patients with serous ovarian carcinoma

47. SALL4: An Intriguing Therapeutic Target in Cancer Treatment.

48. Co-overexpression of self-renewal markers SALL4 and HIWI is correlated with depth of tumor invasion and metastasis in colorectal cancer.

49. DICER1-sarcomas of GYN tract: Expanding on an emerging entity.

50. Silencing AREG Enhances Sensitivity to Irradiation by Suppressing the PI3K/AKT Signaling Pathway in Colorectal Cancer Cells.

Catalog

Books, media, physical & digital resources